Furthermore, RIPK1 kinase activity emerged as driver of ischemic injury18–20 as well as neurodegenerative diseases such as multiple sclerosis (MS)21, ALS (amyotrophic lateral sclerosis)22 and Alzheimer’s disease23. Here, RIPK1 is linked to amyotrophic lateral sclerosis.